Mario A. Quevedo

Cordoba, X, Argentina

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 31 publications

Toward targeted covalent inhibition of Cruzipain for the treatment of Chagas disease.

Toward targeted covalent inhibition of Cruzipain for the treatment of Chagas disease.

Journal: Bioorganic & medicinal chemistry letters

Published: April 17, 2026

Experimental and In Silico Approaches to Study Carboxylesterase Substrate Specificity.

Experimental and In Silico Approaches to Study Carboxylesterase Substrate Specificity.

Journal: Journal of xenobiotics

Published: December 01, 2025

Structure-Based Discovery of Non-Covalent Triazole-Based Cruzipain Inhibitors with Improved Bioactivity Translation.

Structure-Based Discovery of Non-Covalent Triazole-Based Cruzipain Inhibitors with Improved Bioactivity Translation.

Journal: Journal of chemical information and modeling

Published: November 08, 2025

A zinc (II) gentamicin metalloantibiotic with outstanding antimicrobial activity and reduced susceptibility to bacterial resistance mechanisms: Experimental and theoretical explorations.

A zinc (II) gentamicin metalloantibiotic with outstanding antimicrobial activity and reduced susceptibility to bacterial resistance mechanisms: Experimental and theoretical explorations.

Journal: Journal of inorganic biochemistry

Published: August 11, 2025

Exploring human carboxylesterases 1 and 2 selectivity of two families of substrates at an atomistic level.

Exploring human carboxylesterases 1 and 2 selectivity of two families of substrates at an atomistic level.

Journal: Biochimica et biophysica acta. Proteins and proteomics

Published: January 03, 2025

Thiosulfonate-Based Targeted Covalent Cruzipain Inhibitors with Enhanced Bioactivity Translation for Antichagasic Therapy.

Thiosulfonate-Based Targeted Covalent Cruzipain Inhibitors with Enhanced Bioactivity Translation for Antichagasic Therapy.

Journal: ACS medicinal chemistry letters

Published: December 28, 2024

Discovery of a Potent Triazole-Based Reversible Targeted Covalent Inhibitor of Cruzipain.

Discovery of a Potent Triazole-Based Reversible Targeted Covalent Inhibitor of Cruzipain.

Journal: ACS medicinal chemistry letters

Published: September 21, 2024

Structure-Aided Computational Design of Triazole-Based Targeted Covalent Inhibitors of Cruzipain.

Structure-Aided Computational Design of Triazole-Based Targeted Covalent Inhibitors of Cruzipain.

Journal: Molecules (Basel, Switzerland)

Published: July 03, 2024

Design, Synthesis, and Biological Evaluation of New Type of Gemini Analogues with a Cyclopropane Moiety in Their Side Chain.

Design, Synthesis, and Biological Evaluation of New Type of Gemini Analogues with a Cyclopropane Moiety in Their Side Chain.

Journal: Journal of medicinal chemistry

Published: June 10, 2024

Development and Characterization of Pharmaceutical Systems Containing Rifampicin.

Development and Characterization of Pharmaceutical Systems Containing Rifampicin.

Journal: Pharmaceutics

Published: November 18, 2022

Improved Activity of Rifampicin Against Biofilms of Staphylococcus aureus by Multicomponent Complexation.

Improved Activity of Rifampicin Against Biofilms of Staphylococcus aureus by Multicomponent Complexation.

Journal: AAPS PharmSciTech

Published: February 11, 2020

Structure-Activity Relationship Study of an Alkynylphosphonate and Vynilphosphonate Analogues of Calcitriol.

Structure-Activity Relationship Study of an Alkynylphosphonate and Vynilphosphonate Analogues of Calcitriol.

Journal: Medicinal chemistry (Shariqah (United Arab Emirates))

Published: December 12, 2019

Showing 1-12 of 31

Last Updated: 09/26/2026